NO974367D0 - Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller - Google Patents

Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller

Info

Publication number
NO974367D0
NO974367D0 NO974367A NO974367A NO974367D0 NO 974367 D0 NO974367 D0 NO 974367D0 NO 974367 A NO974367 A NO 974367A NO 974367 A NO974367 A NO 974367A NO 974367 D0 NO974367 D0 NO 974367D0
Authority
NO
Norway
Prior art keywords
vectors
methods
well
gene expression
mammalian cells
Prior art date
Application number
NO974367A
Other languages
English (en)
Other versions
NO974367L (no
Inventor
Yin Hwee Tan
Wanjin Hong
Original Assignee
Inst Of Molecul & Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecul & Cell Biology filed Critical Inst Of Molecul & Cell Biology
Publication of NO974367D0 publication Critical patent/NO974367D0/no
Publication of NO974367L publication Critical patent/NO974367L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974367A 1995-03-24 1997-09-22 Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller NO974367L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506051.3A GB9506051D0 (en) 1995-03-24 1995-03-24 Gene expression
PCT/CA1996/000174 WO1996030531A1 (en) 1995-03-24 1996-03-22 Gene expression in mammalian cells

Publications (2)

Publication Number Publication Date
NO974367D0 true NO974367D0 (no) 1997-09-22
NO974367L NO974367L (no) 1997-11-24

Family

ID=10771834

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974367A NO974367L (no) 1995-03-24 1997-09-22 Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller

Country Status (16)

Country Link
US (1) US6207146B1 (no)
EP (1) EP0815251A1 (no)
JP (1) JPH11502705A (no)
KR (1) KR19980703275A (no)
CN (1) CN1185180A (no)
AP (1) AP730A (no)
AU (1) AU722341B2 (no)
BR (1) BR9607831A (no)
CA (1) CA2216174A1 (no)
GB (2) GB9506051D0 (no)
HK (1) HK1005248A1 (no)
HU (1) HUP9800520A3 (no)
IL (1) IL117594A (no)
NO (1) NO974367L (no)
NZ (1) NZ303133A (no)
WO (1) WO1996030531A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
FR2843973B1 (fr) * 2002-08-30 2006-07-07 Agronomique Inst Nat Rech Cassettes d'expression procaryotes regulees par le zinc
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
CN100432230C (zh) * 2006-05-11 2008-11-12 南京大学 一种金属硫蛋白融合表达方法及其应用
AU2008317354B2 (en) * 2007-10-25 2014-04-10 Ospedale San Raffaele S.R.L. Methods and compositions for targeted integration
EP3768846B1 (en) * 2018-03-21 2023-06-21 Aldevron, L.L.C. Viral and non-viral nanoplasmid vectors with improved production

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514567A (en) 1979-01-30 1996-05-07 Juridical Foundation, Japanese Foundation For Cancer Research DNA and recombinant plasmid
AU538665B2 (en) 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
US4966843A (en) 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
DE3688418T2 (de) * 1985-02-13 1993-08-26 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.
GB2177914B (en) * 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US4954437A (en) * 1986-09-15 1990-09-04 Integrated Genetics, Inc. Cell encoding recombinant human erythropoietin
CA1294215C (en) 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
DE3712564A1 (de) 1987-04-14 1988-11-24 Bioferon Biochem Substanz Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta
DD287531A5 (de) 1988-06-16 1991-02-28 Akademie Der Wissenschaften,De Verfahren zur herstellung von humanem wachstumshormon (sth) in tierischen zellen
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0551535A1 (en) 1992-01-13 1993-07-21 SCLAVO S.p.A. Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them

Also Published As

Publication number Publication date
GB9720467D0 (en) 1997-11-26
GB2314332A (en) 1997-12-24
GB2314332B (en) 1999-06-30
KR19980703275A (ko) 1998-10-15
IL117594A0 (en) 1996-07-23
HK1005248A1 (en) 1998-12-31
WO1996030531A1 (en) 1996-10-03
CN1185180A (zh) 1998-06-17
GB9506051D0 (en) 1995-05-10
BR9607831A (pt) 1999-11-30
NZ303133A (en) 1999-11-29
CA2216174A1 (en) 1996-10-03
AU4935896A (en) 1996-10-16
AP9701091A0 (en) 1997-10-31
HUP9800520A3 (en) 1999-09-28
IL117594A (en) 2002-11-10
AP730A (en) 1999-02-04
JPH11502705A (ja) 1999-03-09
HUP9800520A2 (hu) 1998-06-29
US6207146B1 (en) 2001-03-27
AU722341B2 (en) 2000-07-27
NO974367L (no) 1997-11-24
EP0815251A1 (en) 1998-01-07
MX9707244A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
NO975674L (no) Fremgangsmåte for å regulere sialyleringen av proteiner fremstilt av pattedyrceller i kultur
ZA9010392B (en) Method for the modification of the expression characteristics of an endogenous gene of given cell line or microorganism
DE69617583D1 (de) In vitrozellkultur-System
NZ311448A (en) A structurally intact large repeating DNA unit (synthetic or artificial mammalian chromosome) as a vector for gene expression and gene therapy useful for cloning satellite DNA and methods for construction
PT85349A (en) Method for the preparation of proteins with factor viii activity by microbial host cells expression vectors host cells antibodies
HUP0104681A3 (en) Human hybrid host cell for mammalian gene expression
AU5539898A (en) Nucleic acid construct for the cell cycle regulated expression of structural genes
IT1284656B1 (it) Cella elettrolitica
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
DE69613016D1 (de) Elektrochemische Zelle
AU3102289A (en) Regulation of expression in mammalian cells
NO974367D0 (no) Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller
AU5315796A (en) Mammalian expression vectors
AU1428892A (en) Method of lyophilization of mammalian sperm cells
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
GR3034909T3 (en) Methods for producing protein C.
IL97048A0 (en) Bioluminescence assay for gene expression in growing mammalian cells
FI961848A0 (fi) Parannettu solunviljelymenetelmä ja -väliaine
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
ITRM930073A0 (it) Metodo di propagazione in vitro di cellule til.
AU7261496A (en) Use of procaryotic hosts for expression of gene in eucaryotic cells
AU4924199A (en) Repressor proteins producing cell lines for the propagation of vectors
DE69636391D1 (de) Zellzikluskontrollpunkt-spezifische gene
SI1137768T1 (sl) Humana hibridna celica gostiteljica za ekspresijo genov sesalcev

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application